Yttrium-90 labeled anti-CD25 monoclonal antibody

· City of Hope Medical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Yttrium-90 labeled anti-CD25 monoclonal antibody, covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma [Phase 2]

See pricing